SPINOCEREBELLAR ATAXIA 12 (SCA12) DNA DETECTION, EDTA BLOOD

image not found

NABL Cap Accredited    
The SCA12 DNA Detection test identifies abnormal CAG repeat expansions in the PPP2R2B gene, which cause Spinocerebellar Ataxia Type 12. This hereditary condition often presents with action tremors, coordination difficulties, balance issues, and progressive neurological decline. Metropolis Healthcare performs precise molecular analysis using EDTA blood to determine repeat length accurately. Early diagnosis supports appropriate clinical management, prognosis assessment, and genetic counseling for families at risk

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,275.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: S0007

Frequently Asked Questions (FAQ's):

What does the SCA12 DNA detection test look for?
It detects CAG repeat expansions in the PPP2R2B gene linked to Spinocerebellar Ataxia Type 12.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced molecular methods to accurately measure repeat size from EDTA blood.

Who should consider taking this test?
Individuals with tremors, coordination issues, or a family history of SCA12.

What sample is needed for the test?
An EDTA blood sample is required for DNA extraction and analysis.

Does this test confirm the diagnosis?
Yes, identifying an expanded repeat provides a definitive genetic diagnosis.

Is any preparation required before sample collection?
No special preparation or fasting is needed.

How do the results help in patient care?
Results guide diagnosis, monitoring, and enable genetic counseling for affected families.

Can relatives also be tested at Metropolis Healthcare?
Yes, Metropolis Healthcare offers targeted or predictive testing for family members once a mutation is identified

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab